Skip to main content
Top
Published in: BMC Surgery 1/2013

Open Access 01-12-2013 | Research article

Benign proliferative breast diseases among female patients at a sub Saharan Africa tertiary hospital: a cross sectional study

Authors: Christopher Okoth, Moses Galukande, Josephat Jombwe, Dan Wamala

Published in: BMC Surgery | Issue 1/2013

Login to get access

Abstract

Background

Non-cancerous diseases of the breast have assumed increasing importance because of the public awareness of breast cancer. These benign diseases are a recognized important risk factor for later breast cancer which can develop in either breast. The risk estimate of these benign breast diseases has not been well established in sub Saharan Africa. Women with benign proliferative or atypical breast lesions have a two- fold risk of developing breast cancer in western populations. The purpose of this study therefore was to determine the prevalence of proliferative disease ( BPBD) with and without atypia among Ugandan Black women.

Methods

A cross-sectional descriptive study conducted at Mulago Hospital Breast Clinic between January 2012 and June 2012; 208 women aged 12 years and above with palpable breast lumps were screened. Fine needle aspiration biopsies were taken for cytological examination.

Results

Of the 208 women with benign breast lumps screened, 195 were recruited in the study. The prevalence of BPBD was 18% (35/195). BPBD with atypia was 5.6% (11/195). The mean age and body mass index (BMI) were 28.4 years and 23.26 kg/m2 respectively. The commonest lesions were fibroadenomas for 57%, (111/195), and fibrocystic change were 21% (40/195). Most BPBD with atypia lesions were in the fibrocystic category.

Conclusions

Benign proliferative breast diseases are common, found mostly among premenopausal women. A significant proportion of BPBD had atypical proliferation. An accurate breast cancer risk estimate study for BPBD is recommended.
Literature
1.
go back to reference Guray M, Sahin AA: Benign breast diseases: classification, diagnosis and management. Oncologist. 2006, 11 (5): 435-449. 10.1634/theoncologist.11-5-435.CrossRefPubMed Guray M, Sahin AA: Benign breast diseases: classification, diagnosis and management. Oncologist. 2006, 11 (5): 435-449. 10.1634/theoncologist.11-5-435.CrossRefPubMed
2.
go back to reference Armando EG, Doherty GM, Lawrence WW: Current Surgical Diagnosis and Treatment. 2006, 297-300. Benign breast disorders, 2, International Edition, Armando EG, Doherty GM, Lawrence WW: Current Surgical Diagnosis and Treatment. 2006, 297-300. Benign breast disorders, 2, International Edition,
3.
go back to reference Vaidyanathan L, Barnard K, Elnicki DM: Benign breast disease: when to treat, when to reassure, when to refer. Cleve Clin J Med. 2002, 69 (5): 425-432. 10.3949/ccjm.69.5.425.CrossRefPubMed Vaidyanathan L, Barnard K, Elnicki DM: Benign breast disease: when to treat, when to reassure, when to refer. Cleve Clin J Med. 2002, 69 (5): 425-432. 10.3949/ccjm.69.5.425.CrossRefPubMed
5.
go back to reference Olu-Eddo AN, Ugiagbe EE: Benign breast lesions in an african population: a 25-year histopathological review of 1864 cases. Niger Med J. 2011, 52 (4): 211-216. 10.4103/0300-1652.93790.CrossRefPubMedPubMedCentral Olu-Eddo AN, Ugiagbe EE: Benign breast lesions in an african population: a 25-year histopathological review of 1864 cases. Niger Med J. 2011, 52 (4): 211-216. 10.4103/0300-1652.93790.CrossRefPubMedPubMedCentral
6.
go back to reference Echejoh G, Dzuachi D, Jenrola A: Histopathologic analysis of benign breast diseases in Makurdi, North Central Nigeria. International Journal of Medicine and Medical Sciences. 2011, 3 (5): 125-128. Echejoh G, Dzuachi D, Jenrola A: Histopathologic analysis of benign breast diseases in Makurdi, North Central Nigeria. International Journal of Medicine and Medical Sciences. 2011, 3 (5): 125-128.
7.
go back to reference Raju GC, Naraynsingh V: Benign breast disease in a West Indian population. Br J Surg. 1985, 72 (1): 17-18. 10.1002/bjs.1800720108.CrossRefPubMed Raju GC, Naraynsingh V: Benign breast disease in a West Indian population. Br J Surg. 1985, 72 (1): 17-18. 10.1002/bjs.1800720108.CrossRefPubMed
8.
go back to reference Nalwanga S: The pattern of Benign Breast Diseases Seen in Mulago Hospital. Thesis Mmed The pattern of Benign Breast Diseases Seen in Mulago Hospital. 2002, N149- Nalwanga S: The pattern of Benign Breast Diseases Seen in Mulago Hospital. Thesis Mmed The pattern of Benign Breast Diseases Seen in Mulago Hospital. 2002, N149-
9.
go back to reference Santen RJ, Mansel R: Benign breast disorders. N Engl J Med. 2005, 353 (3): 275-285. 10.1056/NEJMra035692.CrossRefPubMed Santen RJ, Mansel R: Benign breast disorders. N Engl J Med. 2005, 353 (3): 275-285. 10.1056/NEJMra035692.CrossRefPubMed
10.
go back to reference Connolly JL, Schnitt SJ: Clinical and histologic aspects of proliferative and non-proliferative benign breast disease. J Cell Biochem Suppl. 1993, 17G: 45-48.CrossRefPubMed Connolly JL, Schnitt SJ: Clinical and histologic aspects of proliferative and non-proliferative benign breast disease. J Cell Biochem Suppl. 1993, 17G: 45-48.CrossRefPubMed
11.
go back to reference Khemka A, Chakrabarti N, Shah S, Patel V: Palpable breast lumps: and fine-needle aspiration cytology versus histopathology: a correlation of diagnostic accuracy. The Internet Journal of Surgery. 2009, 10.5580/1ffb. 18(1). Khemka A, Chakrabarti N, Shah S, Patel V: Palpable breast lumps: and fine-needle aspiration cytology versus histopathology: a correlation of diagnostic accuracy. The Internet Journal of Surgery. 2009, 10.5580/1ffb. 18(1).
12.
go back to reference Zardawi IM, Bennett G, Jain S, Brown M: The role of peer review in internal quality assurance in cytopathology. Pathology. 1998, 30 (3): 309-313. 10.1080/00313029800169506.CrossRefPubMed Zardawi IM, Bennett G, Jain S, Brown M: The role of peer review in internal quality assurance in cytopathology. Pathology. 1998, 30 (3): 309-313. 10.1080/00313029800169506.CrossRefPubMed
13.
go back to reference Wei B, Bu H, Zhu CR, Guo LX, Chen HJ, Zhao C: Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferativebreast diseases. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004, 35 (6): 849-853.PubMed Wei B, Bu H, Zhu CR, Guo LX, Chen HJ, Zhao C: Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferativebreast diseases. Sichuan Da Xue Xue Bao Yi Xue Ban. 2004, 35 (6): 849-853.PubMed
14.
go back to reference Mridha AR, Iyer VK, Kapila K, Verma K: Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology. Indian J Pathol Microbiol. 2006, 49 (3): 334-340.PubMed Mridha AR, Iyer VK, Kapila K, Verma K: Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology. Indian J Pathol Microbiol. 2006, 49 (3): 334-340.PubMed
15.
go back to reference Gakwaya A, Kigula-Mugambe JB, Kavuma A, Luwaga A, Fualal J, Galukande M, Kanyike D: Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008, 99: 63-67. 10.1038/sj.bjc.6604435.CrossRefPubMedPubMedCentral Gakwaya A, Kigula-Mugambe JB, Kavuma A, Luwaga A, Fualal J, Galukande M, Kanyike D: Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer. 2008, 99: 63-67. 10.1038/sj.bjc.6604435.CrossRefPubMedPubMedCentral
16.
go back to reference Sseggwanyi J, Galukande M, Fualal J, Jombwe J: Prevalence of HIV/AIDS among breast cancer patients and the associated clinico-pathological features. Annals of African Surgery. 2011, 8: 22-27. Sseggwanyi J, Galukande M, Fualal J, Jombwe J: Prevalence of HIV/AIDS among breast cancer patients and the associated clinico-pathological features. Annals of African Surgery. 2011, 8: 22-27.
17.
go back to reference Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Sim K: Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Pre Res. 2012, 5 (12): 1375-1380. 10.1158/1940-6207.CAPR-12-0175.CrossRef Cote ML, Ruterbusch JJ, Alosh B, Bandyopadhyay S, Sim K: Benign breast disease and the risk of subsequent breast cancer in African American women. Cancer Pre Res. 2012, 5 (12): 1375-1380. 10.1158/1940-6207.CAPR-12-0175.CrossRef
18.
go back to reference Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M: A multi center prospective cohort study of benign breast disease and risk of seubsequent breast cancer. Cancer Causes Control. 2010, 21 (6): 821-828. 10.1007/s10552-010-9508-7.CrossRefPubMedPubMedCentral Kabat GC, Jones JG, Olson N, Negassa A, Duggan C, Ginsberg M: A multi center prospective cohort study of benign breast disease and risk of seubsequent breast cancer. Cancer Causes Control. 2010, 21 (6): 821-828. 10.1007/s10552-010-9508-7.CrossRefPubMedPubMedCentral
19.
go back to reference Schnitt SJ, Jimi A, Kojiro M: The increasing prevalence of benign proliferative breast lesions in Japanese women. Cancer. 1993, 71 (8): 2528-2531. 10.1002/1097-0142(19930415)71:8<2528::AID-CNCR2820710816>3.0.CO;2-N.CrossRefPubMed Schnitt SJ, Jimi A, Kojiro M: The increasing prevalence of benign proliferative breast lesions in Japanese women. Cancer. 1993, 71 (8): 2528-2531. 10.1002/1097-0142(19930415)71:8<2528::AID-CNCR2820710816>3.0.CO;2-N.CrossRefPubMed
20.
go back to reference Hartmann LC, Sellers TA, Frost MA: Benign breast disease and the risk of breast cancer. N Eng J Med. 2005, 353 (3): 229-237. 10.1056/NEJMoa044383.CrossRef Hartmann LC, Sellers TA, Frost MA: Benign breast disease and the risk of breast cancer. N Eng J Med. 2005, 353 (3): 229-237. 10.1056/NEJMoa044383.CrossRef
21.
go back to reference Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008, 100 (8): 563-571. 10.1093/jnci/djn075.CrossRefPubMed Rohan TE, Negassa A, Chlebowski RT, Habel L, McTiernan A, Ginsberg M: Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008, 100 (8): 563-571. 10.1093/jnci/djn075.CrossRefPubMed
22.
go back to reference Rohan TE: Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev. 2008, 17 (9): 2337-2343. 10.1158/1055-9965.EPI-08-0380.CrossRefPubMedPubMedCentral Rohan TE: Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol Biomarkers Prev. 2008, 17 (9): 2337-2343. 10.1158/1055-9965.EPI-08-0380.CrossRefPubMedPubMedCentral
23.
go back to reference Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D: Risk factors for benign proliferative breast disease. Int J Epidemiol. 2000, 29 (4): 637-644. 10.1093/ije/29.4.637.CrossRefPubMed Friedenreich C, Bryant H, Alexander F, Hugh J, Danyluk J, Page D: Risk factors for benign proliferative breast disease. Int J Epidemiol. 2000, 29 (4): 637-644. 10.1093/ije/29.4.637.CrossRefPubMed
24.
go back to reference Polna I, Aleksandrowicz J: Effect of adsorbents on IgM and IgG measles antibodies. Acta Virol. 1975, 19 (6): 449-456.PubMed Polna I, Aleksandrowicz J: Effect of adsorbents on IgM and IgG measles antibodies. Acta Virol. 1975, 19 (6): 449-456.PubMed
25.
go back to reference Rohan TE, L'Abbe KA, Cook MG: Oral contraceptives and risk of benign proliferative epithelial disorders of the breast. Int J Cancer. 1992, 50 (6): 891-894. 10.1002/ijc.2910500612.CrossRefPubMed Rohan TE, L'Abbe KA, Cook MG: Oral contraceptives and risk of benign proliferative epithelial disorders of the breast. Int J Cancer. 1992, 50 (6): 891-894. 10.1002/ijc.2910500612.CrossRefPubMed
26.
go back to reference Ory H, Cole P, MacMahon B: Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med. 1976, 294: 419-422. 10.1056/NEJM197602192940804.CrossRefPubMed Ory H, Cole P, MacMahon B: Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med. 1976, 294: 419-422. 10.1056/NEJM197602192940804.CrossRefPubMed
27.
go back to reference Zardawi IM, Bennett G, Jain S, Brown M: Internal quality assurance activities of a surgical pathology department in an Australian teaching hospital. J Clin Pathol. 1998, 51 (9): 695-699. 10.1136/jcp.51.9.695.CrossRefPubMedPubMedCentral Zardawi IM, Bennett G, Jain S, Brown M: Internal quality assurance activities of a surgical pathology department in an Australian teaching hospital. J Clin Pathol. 1998, 51 (9): 695-699. 10.1136/jcp.51.9.695.CrossRefPubMedPubMedCentral
28.
go back to reference Hislop TG, Threlfall WJ: Oral contraceptives and benign breast disease. Am J Epidemiol. 1984, 120 (2): 273-280.PubMed Hislop TG, Threlfall WJ: Oral contraceptives and benign breast disease. Am J Epidemiol. 1984, 120 (2): 273-280.PubMed
29.
go back to reference Ahmad N, Zahid J, Faizullah O: Comparison of FNAC and open biopsy in palpable breast lumps. J Coll Physicians Surg Pak. 2004, 14 (11): 654-656.PubMed Ahmad N, Zahid J, Faizullah O: Comparison of FNAC and open biopsy in palpable breast lumps. J Coll Physicians Surg Pak. 2004, 14 (11): 654-656.PubMed
30.
go back to reference Smith MJ, Heffron CC, Rothwell JR, Loftus BM, Jeffers M, Geraghty JG: Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality?. Breast J. 2012, 18 (2): 103-110. 10.1111/j.1524-4741.2012.01223.x.CrossRefPubMed Smith MJ, Heffron CC, Rothwell JR, Loftus BM, Jeffers M, Geraghty JG: Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality?. Breast J. 2012, 18 (2): 103-110. 10.1111/j.1524-4741.2012.01223.x.CrossRefPubMed
Metadata
Title
Benign proliferative breast diseases among female patients at a sub Saharan Africa tertiary hospital: a cross sectional study
Authors
Christopher Okoth
Moses Galukande
Josephat Jombwe
Dan Wamala
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2013
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/1471-2482-13-9

Other articles of this Issue 1/2013

BMC Surgery 1/2013 Go to the issue